Man Group plc - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 158 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.

Quarter-by-quarter ownership
Man Group plc ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$612,258
-42.4%
19,363
-36.4%
0.00%
-50.0%
Q4 2022$1,062,924
-13.1%
30,465
+39.4%
0.00%
-33.3%
Q3 2022$1,223,000
+31.9%
21,854
-32.5%
0.01%
+100.0%
Q3 2018$927,000
-65.5%
32,400
-67.0%
0.00%
-72.7%
Q2 2018$2,689,000
-9.9%
98,300
-30.5%
0.01%
-21.4%
Q1 2018$2,984,000141,5000.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders